232 related articles for article (PubMed ID: 9124855)
21. Characteristics of Stenotrophomonas maltophilia infection in children in Sichuan, China, from 2010 to 2017.
Wang L; Zhou W; Cao Y; Yang C; Liu H; Chen T; Chen L
Medicine (Baltimore); 2020 Feb; 99(8):e19250. PubMed ID: 32080131
[TBL] [Abstract][Full Text] [Related]
22. In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods.
Arpi M; Victor MA; Mortensen I; Gottschau A; Bruun B
APMIS; 1996 Feb; 104(2):108-14. PubMed ID: 8619912
[TBL] [Abstract][Full Text] [Related]
23. Resistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms.
Jia W; Wang J; Xu H; Li G
Int J Environ Res Public Health; 2015 May; 12(5):5177-95. PubMed ID: 25985315
[TBL] [Abstract][Full Text] [Related]
24. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
Leclercq R; Duval J
Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109
[TBL] [Abstract][Full Text] [Related]
25. Activity of Aztreonam in Combination with Avibactam, Clavulanate, Relebactam, and Vaborbactam against Multidrug-Resistant Stenotrophomonas maltophilia.
Biagi M; Lamm D; Meyer K; Vialichka A; Jurkovic M; Patel S; Mendes RE; Bulman ZP; Wenzler E
Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32928733
[TBL] [Abstract][Full Text] [Related]
26. Activities of ciprofloxacin and moxifloxacin against Stenotrophomonas maltophilia and emergence of resistant mutants in an in vitro pharmacokinetic-pharmacodynamic model.
Ba BB; Feghali H; Arpin C; Saux MC; Quentin C
Antimicrob Agents Chemother; 2004 Mar; 48(3):946-53. PubMed ID: 14982788
[TBL] [Abstract][Full Text] [Related]
27. Stenotrophomonas maltophilia susceptibility to ceftazidime-avibactam combination versus ceftazidime alone.
Moriceau C; Eveillard M; Lemarié C; Chenouard R; Pailhoriès H; Kempf M
Med Mal Infect; 2020 May; 50(3):305-307. PubMed ID: 32014291
[TBL] [Abstract][Full Text] [Related]
28. Transferable antibiotic resistance in nosocomial Stenotrophomonas maltophilia strain.
Blahová J; Králiková K; Krcméry V; Torsová V
Diagn Microbiol Infect Dis; 1997 Nov; 29(3):129-32. PubMed ID: 9401804
[TBL] [Abstract][Full Text] [Related]
29. Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia.
Chong SY; Lee K; Chung HS; Hong SG; Suh Y; Chong Y
Microb Drug Resist; 2017 Mar; 23(2):163-168. PubMed ID: 27294684
[TBL] [Abstract][Full Text] [Related]
30. Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methods.
Pankuch GA; Jacobs MR; Rittenhouse SF; Appelbaum PC
Antimicrob Agents Chemother; 1994 Oct; 38(10):2317-22. PubMed ID: 7840563
[TBL] [Abstract][Full Text] [Related]
31. Severe cellulitis/myositis caused by Stenotrophomonas maltophilia.
Downhour NP; Petersen EA; Krueger TS; Tangella KV; Nix DE
Ann Pharmacother; 2002 Jan; 36(1):63-6. PubMed ID: 11816260
[TBL] [Abstract][Full Text] [Related]
32. Induction of Antimicrobial Resistance of
Chatree Y; Charoenlap N; Vanitshavit V; Ruangrassamee P; Mongkolsuk S; Vattanaviboon P
Microb Drug Resist; 2023 Apr; 29(4):115-126. PubMed ID: 36897754
[TBL] [Abstract][Full Text] [Related]
33. Molecular investigation of Stenotrophomonas maltophilia isolates exhibiting rapid emergence of ticarcillin-clavulanate resistance.
Barbier-Frebour N; Boutiba-Boubake I; Nouvello M; Lemelan J
J Hosp Infect; 2000 May; 45(1):35-41. PubMed ID: 10833341
[TBL] [Abstract][Full Text] [Related]
34. Antibiotic susceptibility of Stenotrophomonas (Xanthomonas) maltophilia: comparative (NCCLS criteria) evaluation of antimicrobial drugs with the agar dilution and the agar disk diffusion (Bauer-Kirby) tests.
Traub WH; Leonhard B; Bauer D
Chemotherapy; 1998; 44(3):164-73. PubMed ID: 9612606
[TBL] [Abstract][Full Text] [Related]
35. [Surveillance on antibiotic resistance of Stenotrophomonas maltophilia in Chengdu and Chongqing area].
Tao CM; Li XC; Lü XJ; Li P; Yu RJ; Gao YY; Chen HL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):91-3. PubMed ID: 14981826
[TBL] [Abstract][Full Text] [Related]
36. Endocarditis caused by Stenotrophomonas maltophilia: case report and review.
Gutiérrez Rodero F; Masiá MM; Cortés J; Ortiz de la Tabla V; Mainar V; Vilar A
Clin Infect Dis; 1996 Dec; 23(6):1261-5. PubMed ID: 8953069
[TBL] [Abstract][Full Text] [Related]
37. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999).
Gales AC; Jones RN; Forward KR; Liñares J; Sader HS; Verhoef J
Clin Infect Dis; 2001 May; 32 Suppl 2():S104-13. PubMed ID: 11320451
[TBL] [Abstract][Full Text] [Related]
38. Antibiotics resistance of Stenotrophomonas maltophilia strains isolated from various clinical specimens.
Çıkman A; Parlak M; Bayram Y; Güdücüoğlu H; Berktaş M
Afr Health Sci; 2016 Mar; 16(1):149-52. PubMed ID: 27358626
[TBL] [Abstract][Full Text] [Related]
39. [Investigation of the presence of class 1, 2, 3 integrons and their relationships with antibiotic resistance in clinical Stenotrophomonas maltophilia isolates].
Usta E; Eroğlu C; Yanık K; Karadağ A; Güney AK; Günaydın M
Mikrobiyol Bul; 2015 Jan; 49(1):35-46. PubMed ID: 25706729
[TBL] [Abstract][Full Text] [Related]
40. Impacts of L1 Promoter Variation and L2 Clavulanate Susceptibility on Ticarcillin-Clavulanate Susceptibility of Stenotrophomonas maltophilia.
Huang HH; Chen PY; Hu RM; Lin YT; Li LH; Yang TC
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]